Physician profile
Brian P Grady
NPI 1417018813
$8,416.55
in general payments reported to CMS, 2019-2025
33 companies · $2,249 in 2025
The $2,249 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $984 · 2020: $669 · 2021: $580 · 2022: $1,418 · 2023: $1,337 · 2024: $1,181 · 2025: $2,249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,137 · Travel and Lodging: $1,629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,136.95 |
| Travel and Lodging | $1,629.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Profound Medical Corp. | $2,643.83 | 2024-2025 | Tulsa-Pro |
| Endo Pharmaceuticals INC. | $1,179.07 | 2019-2024 | Xiaflex, Aveed |
| Urovant Sciences INC | $838.62 | 2021-2022 | |
| Astellas Pharma US INC | $516.68 | 2019-2023 | Myrbetriq, Xtandi |
| Sumitomo Pharma America, INC. | $473.98 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $394.84 | 2019-2023 | Provenge |
| Janssen Biotech, INC. | $330.41 | 2019-2022 | |
| Endo USA, INC. | $317.20 | 2024-2025 | Xiaflex, Aveed |
| Boston Scientific Corporation | $273.67 | 2019-2021 | |
| Abbvie INC. | $209.19 | 2022-2025 | |
| Pfizer INC. | $173.03 | 2019-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.68 | 2019-2023 | |
| Antares Pharma, INC. | $122.37 | 2022-2023 | Nocdurna, Xyosted, Tlando |
| Accord Healthcare, INC. | $85.24 | 2022-2023 | |
| Urogen Pharma, INC. | $83.33 | 2022-2025 | Jelmyto |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $72.00 | 2019 | |
| Amgen INC. | $61.48 | 2022-2023 | Xgeva |
| Karl Storz Endoscopy-America | $55.36 | 2020-2024 | N.A. |
| Procept Biorobotics Corporation | $49.42 | 2024-2025 | Aquabeam System |
| Coloplast Corp | $42.89 | 2023-2024 | Porges Coloplast |
| Ferring Pharmaceuticals INC. | $38.74 | 2019 | |
| Blue Earth Diagnostics | $38.41 | 2022-2023 | |
| 180 Medical, INC. | $36.77 | 2019-2023 | Cure Catheter |
| Teleflex LLC | $36.24 | 2025 | Barrigel |
| Novartis Pharmaceuticals Corporation | $32.59 | 2025 | |
| Dentsply Ih INC. | $30.00 | 2019 | |
| Merck Sharp & Dohme LLC | $28.85 | 2023 | Lynparza, Keytruda |
| Tolmar, INC. | $28.45 | 2023 | |
| C. R. Bard, INC. & Subsidiaries | $25.61 | 2023 | Bard Urinary Drainage Bag |
| Laborie Medical Technologies Corp. | $19.05 | 2020 | |
| Olympus America INC. | $18.35 | 2022 | |
| Photocure INC | $18.04 | 2022 | |
| Halozyme INC | $17.16 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Grady listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.